在慢性鼻炎的发病因子上康斯塔丁M的参与:关注1型和2型炎症
Chie Ishikawa1, Sachio Takeno1, Yukako Okamoto1
1Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Biomedicines
|December 23, 2023
概括
在慢性鼻炎 (CRS) 中,甲素M (OSM) 含量升高,与炎症标志物相关. 这表明OSM信号通路是CRS的潜在治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 分子生物学分子生物学
背景情况:
- Kostatin M (OSM) 干扰了上皮层屏障的功能.
- 在慢性鼻炎 (CRS) 病原发生过程中OSM的作用尚未完全理解.
- 在CRS中研究OSM及其受体 (OSMR) 对于理解炎症至关重要.
研究的目的:
- 检查CRS鼻腔组织中的OSM和OSMR表达.
- 为了将OSM水平与炎症性细胞因子和CRS的临床特征相关联.
- 评估OSM对上皮细胞细胞系中细胞因子受体表达的影响.
主要方法:
- 在CRS中对OSM和OSMRmRNA进行RT-PCR分析,并控制鼻腔粘膜.
- 根据CRS患者的表型分类,将其分为色素 (ECRS) 和非色素 (非ECRS) 组.
- 使用BEAS-2B细胞进行体外研究,以评估OSM对细胞因子受体表达的影响.
主要成果:
- 显著增加的OSM mRNA水平在CRS的ethmoid sinus粘膜中被观察到.
- 在OSM mRNA水平与TNF-α,IL-1β,IL-13和OSMR-β正相关.
- 在BEAS-2B细胞中的OSM治疗上调了OSMRβ,IL-1R1和IL-13RamRNA.
结论:
- 在CRS中,OSM在1型和2型炎症的发病过程中起作用.
- OSM信号通路代表了CRS的潜在治疗目标.
- 通过OSM信号调节上皮层-层相互作用可能对CRS治疗有益.
关键词:
在CRS中,您可以使用CRS.这就是OSM OSM.在OSM受体上,OSM受体是这是OSMR的OSMR.慢性鼻鼻炎是什么埃奥西诺菲尔是什么意思皮质细胞上皮质细胞上皮质细胞在costatin M上鼻上鼻 (Paranasal Sinus) 是一个鼻.更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Asthma: Pathogenesis and Management
411
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
411
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305
Cystic Fibrosis: Management
170
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
170
Drugs Used in Lower Respiratory Disorders: Overview
449
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
449


